Albemarle Corporation (ALB) Stock Analysis
Latest ClaritX AI analysis ·
Albemarle Corporation stands as a global innovator, producing and distributing a diverse portfolio of engineered specialty chemicals. Its business operations are divided into three principal segments: Lithium, Bromine, and Catalysts. The Lithium division supplies a variety of lithium compounds, including lithium carbonate, hydroxide, and chloride, alongside critical reagents like butyllithium. These materials are vital for manufacturing lithium-ion batteries found in electric vehicles and consumer electronics, as well as for high-performance greases, thermoplastic elastomers used in tires and plastics, and as catalysts for chemical reactions, organic synthesis in areas like steroid chemistry
| Metric | Value |
|---|---|
| Price | $106.35 |
| Market cap | $12.5B |
| Sector | Basic Materials |
| Industry | Chemicals - Specialty |
| ClaritX AI score | 71/100 |
| Price/Book | 1.22 |
| Dividend yield | 1.53% |
| Beta | 1.36 |
AI verdict
Albemarle Corporation (ALB) presents an exceptionally compelling, deeply contrarian value proposition defined by extreme cyclical pricing dislocations, pristine balance sheet health, and aggressive, coordinated institutional accumulation. Currently trading at $106.35, the stock is stationed at a massive 51.8% discount relative to its established 52-week high of $221.00. This stark structural markdown is mathematically amplified by an elevated beta coefficient of 1.359, explicitly underscoring the aggressive cyclical volatility inherent in the specialty chemicals sector. However, intelligently allocating capital to a fundamentally superior, cash-flow-generative industrial titan near multi-year cyclical lows offers a profoundly de-risked, highly asymmetric opportunity compared to buying overextended equities at euphoric market tops. The downside is structurally capped by the sheer gravity of its immense asset base and a massive $1.3 billion recent debt reduction. The enterprise remains an absolute financial fortress, boasting an ultra-conservative 0.193 debt-to-equity ratio and an incredible $11.38 in free cash flow per share, allowing it to easily outlast junior competitors facing insolvency while funding a secure 1.53% dividend yield. The institutional footprint is overwhelmingly bullish, perfectly paired with an aggressive 10-to-1 insider buy-to-sell transaction ratio in Q3 2026. Supported by recent deleveraging validations, an average near-term analyst price target of $151
What this score has been worth
ClaritX scores ALB 71 out of 100 (snapshot 2026-10-15).
Every ClaritX analysis is scored first and judged only on what the stock did afterwards. Across the 301 analyses that scored in the 70-79 band, the average forward return was +1.5% with a 53% win rate, -2.8pp against the S&P 500. That is a measured tendency across many names, not a forecast for ALB — roughly 47% of stocks in this band still lost money.
The full band-by-band table, including the bands that lost, is on the AI Rank Report; the live strategy arms behind it are on the AI Track Record, losses published.